Instil Bio, Inc.
TIL
$7.61
$0.030.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.26% | 48.68% | 39.71% | 36.49% | 24.13% |
| Total Depreciation and Amortization | 1,966.67% | 0.00% | 0.00% | 0.00% | -97.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.53% | 59.79% | -57.18% | -80.44% | -41.48% |
| Change in Net Operating Assets | -261.45% | 913.28% | -82.73% | 114.68% | -239.49% |
| Cash from Operations | -247.20% | 81.11% | 32.97% | 28.63% | -252.59% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 80.00% | -61.54% | -96.79% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,769.09% | -104.06% | -7.50% | 2,144.07% | -104.49% |
| Cash from Investing | 1,769.09% | -104.05% | -7.45% | 2,211.75% | -104.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -94.59% | 1,628.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -74.42% |
| Cash from Financing | -- | -- | -100.00% | -94.34% | 2,780.17% |
| Foreign Exchange rate Adjustments | 120.00% | 73.68% | 24.00% | -219.05% | -51.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.18% | -329.46% | 141.15% | 79.30% | -249.15% |